| abstract |
The invention generally relates to recombinant alphavirus vectors comprising a 5 ' UTR, sequences encoding non-structural genes nsP1, nsP2, nsP3, and nsP4, and a sequence that is operably linked to an expression control sequence and encoding a heterologous protein; engineered to produce desired levels of heterologous protein expression and/or interferon induction. |